Complete Filing Data
FILANA THERAPEUTICS, INC. reported Net Income Loss of -$90.97 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean FILANA THERAPEUTICS, INC. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$91.0M | -$24.3M | -$97.2M | -$76.2M | -$32.4M | -$6.3M | -$4.6M | -$6.6M | -$11.9M | -$14.9M | -$14.1M | -$12.4M | $31.5M | -$3.4M | -$2.6M | -$12.0M | -$3.5M |
| Operating Income Loss | -$95.4M | -$141.4M | -$106.0M | -$80.0M | -$32.9M | -$6.4M | -$5.0M | -$6.7M | -$11.9M | -$15.0M | -$14.2M | -$12.4M | $31.4M | -$3.9M | -$3.5M | -$13.7M | -$6.8M |
| Operating Expenses | $95.4M | $141.4M | $106.0M | $80.0M | $32.9M | $6.4M | $5.0M | $6.7M | $11.9M | $15.0M | $14.2M | $12.4M | $9.8M | $14.8M | $15.0M | $30.5M | $27.3M |
| General And Administrative Expense | $68.8M | $71.8M | $16.5M | $12.0M | $8.1M | $3.7M | $3.4M | $3.7M | $4.3M | $5.8M | $5.1M | $5.1M | $4.8M | $7.2M | $6.7M | $14.8M | $6.3M |
| Research And Development Expense | $26.6M | $69.6M | $89.4M | $68.0M | $24.8M | $3.0M | $7.6M | $9.2M | $9.1M | $7.3M | $4.9M | $7.6M | $8.3M | $15.7M | $21.1M | ||
| Comprehensive Income Net Of Tax | -$11.9M | -$14.9M | -$14.1M | -$12.4M | $31.5M | -$3.6M | -$3.0M | -$11.8M | -$3.4M | ||||||||
| Sales Revenue Net | $41.1M | $10.9M | $11.5M | $16.8M | $20.6M | ||||||||||||
| Other Nonoperating Income Expense | -$203.0K | $411.0K | $907.0K | $997.0K | $434.0K | ||||||||||||
| Research And Development Expense Net Of Grant Reimbursement | $68.0M | $24.8M | $3.1M | $1.6M | $3.0M | ||||||||||||
| Program Fee Revenue | $41.1M | $10.6M | $10.9M | $10.5M | $14.3M | ||||||||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -$1.0K | -$3.0K | -$124.0K | -$397.0K | $178.0K | $22.0K | |||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$14.1M | -$12.4M | $31.5M | -$3.4M | -$2.6M | -$12.0M | -$5.0M | ||||||||||
| Amortization Of Intangible Assets | $33.0K | $180.0K | $446.0K | $497.0K | $224.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q1 2012 | Q4 2011 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$10.8M | -$44.2M | -$23.4M | -$27.9M | $6.2M | $25.0M | -$25.7M | -$26.4M | -$24.3M | -$20.3M | -$19.3M | -$17.5M | -$9.6M | -$5.1M | -$3.5M | -$1.4M | -$1.1M | -$1.2M | -$697.0K | -$1.1M | -$1.4M | -$1.3M | -$2.5M | -$2.2M | -$2.6M | -$4.2M | -$2.7M | -$2.5M | -$3.5M | -$3.0M | -$5.8M | -$4.5M | -$3.7M | -$3.4M | -$2.6M | -$2.2M | -$3.5M | -$3.2M | -$3.5M | -$762.0K | -$301.0K | -$408.0K | -$1.6M | -$130.0K | $30.0K | -$815.0K | -$1.2M | -$207.0K | -$1.0M | -$804.0K | |||
| Operating Income Loss | -$11.9M | -$45.4M | -$24.6M | -$30.6M | -$61.4M | -$19.9M | -$27.9M | -$28.8M | -$26.5M | -$21.3M | -$19.9M | -$17.8M | -$9.8M | -$5.1M | -$3.5M | -$1.4M | -$1.2M | -$1.2M | -$779.0K | -$1.2M | -$1.5M | -$1.3M | -$2.5M | -$2.2M | -$2.6M | -$4.2M | -$2.8M | -$3.5M | -$3.0M | -$5.8M | -$3.7M | -$3.4M | -$2.6M | -$3.5M | -$3.3M | -$3.5M | -$776.0K | -$319.0K | -$443.0K | -$1.7M | -$253.0K | -$148.0K | -$1.0M | -$1.4M | -$479.0K | -$1.6M | -$1.3M | ||||||
| Operating Expenses | $11.9M | $45.4M | $24.6M | $30.6M | $61.4M | $19.9M | $27.9M | $28.8M | $26.5M | $21.3M | $19.9M | $17.8M | $9.8M | $5.1M | $3.5M | $1.4M | $1.2M | $1.2M | $779.0K | $1.2M | $1.5M | $1.3M | $2.5M | $2.2M | $2.6M | $4.2M | $2.8M | $3.5M | $3.0M | $5.8M | $3.7M | $3.4M | $2.6M | $3.5M | $3.3M | $3.5M | $2.7M | $2.3M | $2.4M | $4.4M | $3.0M | $3.1M | $3.8M | $4.2M | $3.7M | $4.5M | $3.9M | ||||||
| General And Administrative Expense | $7.9M | $40.3M | $10.9M | $12.9M | $46.2M | $3.7M | $4.3M | $3.8M | $4.4M | $2.8M | $3.0M | $2.9M | $1.7M | $1.2M | $1.0M | $1.0M | $818.0K | $778.0K | $831.0K | $845.0K | $877.0K | $848.0K | $998.0K | $1.1M | $977.0K | $1.1M | $1.4M | $884.0K | $1.5M | $2.2M | $1.3M | $1.4M | $1.5M | $1.4M | $1.3M | $1.3M | $1.3M | $1.1M | $1.2M | $2.0M | $1.5M | $1.5M | $1.8M | $1.8M | $1.5M | $2.1M | $1.7M | ||||||
| Research And Development Expense | $4.0M | $5.1M | $13.7M | $17.7M | $15.2M | $16.2M | $23.6M | $25.0M | $22.1M | $18.5M | $308.0K | $574.0K | $1.5M | $1.5M | $1.1M | $1.6M | $3.1M | $1.4M | $2.7M | $1.6M | $3.6M | $2.4M | $2.0M | $1.1M | $2.1M | $1.9M | $2.1M | $1.4M | $1.1M | $1.2M | $2.4M | $1.5M | $1.6M | $2.0M | $2.4M | $2.2M | $2.4M | $2.2M | |||||||||||||||
| Comprehensive Income Net Of Tax | -$2.5M | -$2.2M | -$2.6M | -$4.2M | -$2.7M | -$3.5M | -$3.0M | -$5.8M | -$3.7M | -$3.4M | -$2.6M | -$3.5M | -$3.2M | -$3.5M | -$763.0K | -$301.0K | -$411.0K | -$1.6M | -$183.0K | -$2.0K | -$1.1M | -$1.3M | -$264.0K | ||||||||||||||||||||||||||||||
| Sales Revenue Net | $35.2M | $2.0M | $2.0M | $2.0M | $2.5M | $2.7M | $2.7M | $3.0M | $2.7M | $2.7M | $2.8M | $3.2M | $2.9M | $2.7M | |||||||||||||||||||||||||||||||||||||||
| Other Nonoperating Income Expense | -$114.0K | -$46.0K | -$82.0K | $62.0K | $99.0K | $160.0K | $223.0K | $203.0K | $190.0K | $210.0K | $275.0K | $263.0K | $176.0K | ||||||||||||||||||||||||||||||||||||||||
| Research And Development Expense Net Of Grant Reimbursement | $25.0M | $22.1M | $18.5M | $16.9M | $14.9M | $8.0M | $3.9M | $2.5M | $399.0K | $591.0K | $544.0K | -$52.0K | $308.0K | $574.0K | $436.0K | ||||||||||||||||||||||||||||||||||||||
| Program Fee Revenue | $2.0M | $2.0M | $2.0M | $2.7M | $2.7M | $2.7M | $2.7M | $2.7M | $2.7M | $2.7M | $2.5M | ||||||||||||||||||||||||||||||||||||||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $1.0K | -$1.0K | -$1.0K | -$3.0K | -$41.0K | -$53.0K | -$32.0K | -$273.0K | -$74.0K | -$57.0K | |||||||||||||||||||||||||||||||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$4.5M | -$3.7M | -$3.4M | -$2.6M | -$2.2M | -$3.5M | -$3.2M | -$3.5M | $33.0M | -$762.0K | -$301.0K | -$408.0K | -$1.8M | -$1.6M | -$130.0K | $30.0K | |||||||||||||||||||||||||||||||||||||
| Amortization Of Intangible Assets | $32.0K | $56.0K | $61.0K | $119.0K | $119.0K | $119.0K | $119.0K | $125.0K | $135.0K | $90.0K | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents At Carrying Value | $95.5M | $128.6M | $121.1M | $201.0M | $233.4M | $93.5M | $19.8M | $10.5M | $16.6M | $31.3M | $40.6M | $48.6M | $49.4M | $73.1M | $4.8M | $35.8M | $153.2M | |
| Stockholders Equity | $74.4M | $145.7M | $137.5M | $227.5M | $253.9M | $92.2M | $22.1M | $19.6M | $9.7M | $18.6M | $29.4M | $40.1M | $48.3M | $13.1M | $44.4M | $32.9M | $108.3M | $104.3M |
| Retained Earnings Accumulated Deficit | -$496.1M | -$405.1M | -$380.8M | -$283.6M | -$207.3M | -$174.9M | -$168.6M | -$164.0M | -$157.4M | -$145.5M | -$130.6M | -$116.5M | -$104.1M | -$135.7M | -$132.2M | -$129.6M | ||
| Liabilities Current | $43.8M | $11.8M | $14.2M | $7.1M | $12.5M | $1.9M | $1.4M | $511.0K | $1.1M | $665.0K | $2.6M | $850.0K | $1.8M | $10.0M | $13.3M | $14.1M | ||
| Liabilities And Stockholders Equity | $118.4M | $157.5M | $151.7M | $234.8M | $266.8M | $94.3M | $23.5M | $20.1M | $10.8M | $19.3M | $31.9M | $40.9M | $50.1M | $56.9M | $99.0M | $99.2M | ||
| Employee Related Liabilities Current | $1.6M | $1.4M | $200.0K | $170.0K | $1.9M | $83.0K | $58.0K | $61.0K | $309.0K | $335.0K | $623.0K | $652.0K | $712.0K | $853.0K | $915.0K | $1.7M | ||
| Common Stock Value | $48.0K | $48.0K | $42.0K | $42.0K | $40.0K | $35.0K | $22.0K | $17.0K | $7.0K | $7.0K | $46.0K | $46.0K | $45.0K | $45.0K | $45.0K | $43.0K | ||
| Assets Current | $97.7M | $136.5M | $129.6M | $211.2M | $244.5M | $94.0M | $23.3M | $20.0M | $10.7M | $19.1M | $31.7M | $40.8M | $50.1M | $56.5M | $98.5M | $98.5M | ||
| Assets | $118.4M | $157.5M | $151.7M | $234.8M | $266.8M | $94.3M | $23.5M | $20.1M | $10.8M | $19.3M | $31.9M | $40.9M | $50.1M | $56.9M | $99.0M | $99.2M | ||
| Liabilities | $44.0M | $11.8M | $14.2M | $7.3M | $12.9M | $2.1M | $1.4M | $511.0K | $1.1M | $665.0K | $2.6M | $850.0K | $1.8M | $43.7M | $54.6M | $66.3M | ||
| Property Plant And Equipment Net | $20.6M | $21.0M | $21.9M | $22.9M | $20.6M | $11.0K | $47.0K | $87.0K | $156.0K | $232.0K | $215.0K | $65.0K | $122.0K | $285.0K | ||||
| Accounts Payable Current | $7.1M | $911.0K | $453.0K | $294.0K | $424.0K | $303.0K | $1.0M | $173.0K | $445.0K | $361.0K | $464.0K | $1.1M | ||||||
| Other Assets Current | $268.0K | $233.0K | $184.0K | $356.0K | $392.0K | $239.0K | $265.0K | $253.0K | $358.0K | $144.0K | ||||||||
| Cash And Cash Equivalents Period Increase Decrease | $9.3M | -$6.1M | -$14.7M | -$9.3M | -$8.0M | -$767.0K | -$23.8M | $68.3M | -$31.0M | -$117.4M | ||||||||
| Other Assets Noncurrent | $399.0K | $12.0K | $12.0K | $12.0K | $12.0K | $352.0K | $352.0K | $426.0K | ||||||||||
| Accrued Liabilities Current | $2.8M | $719.0K | $777.0K | $156.0K | $399.0K | $27.0K | $894.0K | $25.0K | ||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$33.1M | $7.4M | -$79.9M | -$32.4M | $139.9M | $70.4M | $3.3M | $9.3M | ||||||||||
| Accrued Development Expense Current | $364.0K | $2.4M | $3.0M | $2.3M | $641.0K | $929.0K | $914.0K | $258.0K | ||||||||||
| Other Liabilities Current | $198.0K | $299.0K | $385.0K | $492.0K | $631.0K | $94.0K | $9.0K | |||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $95.5M | $128.6M | $121.1M | $201.0M | $233.4M | $93.5M | ||||||||||||
| Prepaid Expense And Other Assets Current | $2.2M | $8.0M | $8.5M | $10.2M | $11.0M | $488.0K | ||||||||||||
| Marketable Securities Current | $2.1M | $1.3M | $6.9M | $25.0M | $86.4M | |||||||||||||
| Operating Lease Right Of Use Asset | $0.00 | $122.0K | $210.0K | $295.0K | $90.0K | |||||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $1.0K | $1.0K | $4.0K | $128.0K | $525.0K | |||||||||||||
| Operating Lease Liability Current | $0.00 | $104.0K | $97.0K | $58.0K | $90.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents At Carrying Value | $106.1M | $112.4M | $117.3M | $149.0M | $207.3M | $124.2M | $142.4M | $168.4M | $187.5M | $174.7M | $197.2M | $209.7M | $241.5M | $278.3M | $282.2M | $24.1M | $25.3M | $25.6M | $23.1M | $17.8M | $18.5M | $19.1M | $20.4M | $9.6M | $10.7M | $11.9M | $14.1M | $17.3M | $21.2M | $24.6M | $26.6M | $34.0M | $36.4M | $37.2M | $42.1M | $44.6M | $45.9M | $49.7M | $51.5M | $51.6M | $88.2M | $79.0M | $73.8M | $71.7M | $62.8M | $54.9M | $106.3M | $66.8M | |||
| Stockholders Equity | $81.6M | $88.0M | $127.6M | $166.6M | $189.0M | $78.6M | $155.1M | $179.4M | $204.0M | $198.7M | $218.4M | $237.1M | $267.6M | $276.5M | $281.2M | $24.0M | $24.2M | $24.8M | $17.4M | $17.8M | $18.6M | $20.0M | $8.5M | $10.3M | $11.4M | $13.3M | $16.7M | $20.3M | $23.0M | $25.3M | $33.1M | $35.9M | $38.4M | $41.2M | $43.7M | $45.7M | $14.3M | $14.2M | $13.4M | $46.3M | $46.2M | $45.3M | $43.5M | $43.0M | |||||||
| Retained Earnings Accumulated Deficit | -$483.5M | -$472.7M | -$428.5M | -$377.5M | -$349.6M | -$355.7M | -$359.9M | -$334.2M | -$307.8M | -$264.4M | -$244.2M | -$224.8M | -$193.1M | -$183.6M | -$178.4M | -$172.3M | -$170.9M | -$169.7M | -$167.1M | -$166.4M | -$165.3M | -$163.3M | -$162.0M | -$159.6M | -$155.0M | -$152.4M | -$148.2M | -$143.0M | -$139.4M | -$136.4M | -$126.1M | -$122.5M | -$119.1M | -$114.3M | -$110.8M | -$107.6M | -$137.1M | -$136.4M | -$136.1M | -$133.9M | -$132.3M | -$132.2M | -$131.8M | -$131.0M | |||||||
| Liabilities Current | $48.0M | $47.3M | $13.2M | $57.0M | $54.6M | $77.1M | $17.4M | $17.9M | $13.9M | $8.3M | $8.7M | $6.8M | $6.3M | $4.6M | $2.7M | $1.2M | $1.3M | $1.1M | $907.0K | $937.0K | $902.0K | $862.0K | $1.3M | $758.0K | $1.0M | $999.0K | $883.0K | $2.2M | $2.0M | $3.3M | $2.6M | $1.8M | $1.2M | $2.4M | $1.7M | $1.6M | $9.7M | $9.2M | $9.7M | $13.8M | $12.4M | $12.9M | $13.1M | $12.8M | |||||||
| Liabilities And Stockholders Equity | $129.7M | $135.4M | $140.9M | $223.8M | $243.6M | $155.7M | $172.5M | $197.2M | $218.1M | $207.3M | $227.4M | $244.2M | $274.2M | $281.3M | $284.1M | $25.4M | $25.5M | $26.0M | $18.4M | $18.8M | $19.5M | $20.8M | $9.8M | $11.1M | $12.4M | $14.3M | $17.6M | $22.5M | $24.9M | $28.6M | $35.7M | $37.8M | $39.6M | $43.6M | $45.4M | $47.3M | $51.8M | $53.2M | $54.9M | $93.3M | $94.4M | $96.8M | $100.6M | $102.6M | |||||||
| Employee Related Liabilities Current | $362.0K | $563.0K | $855.0K | $2.0M | $218.0K | $228.0K | $187.0K | $220.0K | $212.0K | $160.0K | $176.0K | $172.0K | $126.0K | $120.0K | $99.0K | $80.0K | $84.0K | $72.0K | $55.0K | $60.0K | $62.0K | $305.0K | $313.0K | $309.0K | $298.0K | $309.0K | $302.0K | $340.0K | $934.0K | $1.5M | $1.0M | $900.0K | $738.0K | $1.2M | $1.0M | $879.0K | $550.0K | $379.0K | $1.1M | $1.6M | $377.0K | $1.1M | $785.0K | $632.0K | |||||||
| Common Stock Value | $48.0K | $48.0K | $48.0K | $48.0K | $48.0K | $43.0K | $42.0K | $42.0K | $42.0K | $40.0K | $40.0K | $40.0K | $40.0K | $40.0K | $40.0K | $26.0K | $25.0K | $25.0K | $17.0K | $17.0K | $17.0K | $17.0K | $7.0K | $7.0K | $7.0K | $7.0K | $46.0K | $46.0K | $46.0K | $46.0K | $46.0K | $46.0K | $46.0K | $45.0K | $45.0K | $45.0K | $45.0K | $45.0K | $45.0K | $45.0K | $45.0K | $45.0K | $45.0K | $45.0K | |||||||
| Assets Current | $108.9M | $114.8M | $120.2M | $202.5M | $222.1M | $134.0M | $150.2M | $174.5M | $195.0M | $183.3M | $204.2M | $222.2M | $251.9M | $279.6M | $283.8M | $25.1M | $25.4M | $25.9M | $18.2M | $18.6M | $19.3M | $20.7M | $9.7M | $10.9M | $12.2M | $14.1M | $17.4M | $22.2M | $24.7M | $28.4M | $35.4M | $37.5M | $39.4M | $43.5M | $45.3M | $47.2M | $51.4M | $52.8M | $54.5M | $92.9M | $94.0M | $96.4M | $100.1M | $102.0M | |||||||
| Assets | $129.7M | $135.4M | $140.9M | $223.8M | $243.6M | $155.7M | $172.5M | $197.2M | $218.1M | $207.3M | $227.4M | $244.2M | $274.2M | $281.3M | $284.1M | $25.4M | $25.5M | $26.0M | $18.4M | $18.8M | $19.5M | $20.8M | $9.8M | $11.1M | $12.4M | $14.3M | $17.6M | $22.5M | $24.9M | $28.6M | $35.7M | $37.8M | $39.6M | $43.6M | $45.4M | $47.3M | $51.8M | $53.2M | $54.9M | $93.3M | $94.4M | $96.8M | $100.6M | $102.6M | |||||||
| Liabilities | $48.2M | $47.4M | $13.3M | $57.1M | $17.4M | $17.9M | $14.1M | $8.6M | $9.0M | $7.1M | $6.7M | $4.8M | $2.9M | $1.4M | $1.3M | $1.1M | $930.0K | $982.0K | $970.0K | $862.0K | $1.3M | $758.0K | $1.0M | $999.0K | $883.0K | $2.2M | $2.0M | $3.3M | $2.6M | $1.8M | $1.2M | $2.4M | $1.7M | $1.6M | $37.5M | $39.0M | $41.5M | $46.9M | $48.3M | $51.5M | $57.1M | $59.6M | |||||||||
| Property Plant And Equipment Net | $20.8M | $20.6M | $20.8M | $21.1M | $21.4M | $21.6M | $22.1M | $22.3M | $22.6M | $23.1M | $22.2M | $20.9M | $20.7M | $75.0K | $10.0K | $12.0K | $13.0K | $33.0K | $61.0K | $75.0K | $88.0K | $104.0K | $122.0K | $139.0K | $173.0K | $190.0K | $214.0K | $250.0K | $187.0K | $201.0K | $228.0K | $242.0K | $256.0K | $69.0K | $72.0K | $76.0K | $52.0K | $87.0K | $157.0K | $192.0K | |||||||||||
| Accounts Payable Current | $10.3M | $8.2M | $4.0M | $3.5M | $4.8M | $3.3M | $2.3M | $1.9M | $864.0K | $465.0K | $416.0K | $608.0K | $340.0K | $594.0K | $495.0K | $549.0K | $962.0K | $421.0K | $712.0K | $658.0K | $573.0K | $1.1M | $378.0K | $1.0M | $898.0K | $465.0K | $255.0K | $822.0K | $360.0K | $428.0K | $531.0K | $435.0K | $366.0K | $507.0K | $501.0K | $502.0K | $556.0K | $604.0K | |||||||||||||
| Other Assets Current | $1.6M | $488.0K | $997.0K | $186.0K | $277.0K | $385.0K | $49.0K | $140.0K | $276.0K | $91.0K | $155.0K | $288.0K | $12.0K | $126.0K | $456.0K | $115.0K | $299.0K | $520.0K | $200.0K | $119.0K | $358.0K | $482.0K | $141.0K | $389.0K | $3.0K | $127.0K | $378.0K | $95.0K | $475.0K | $493.0K | $15.0K | ||||||||||||||||||||
| Cash And Cash Equivalents Period Increase Decrease | -$682.0K | $255.0K | $649.0K | -$4.7M | -$3.3M | -$2.7M | $2.2M | $635.0K | $50.1M | ||||||||||||||||||||||||||||||||||||||||||
| Other Assets Noncurrent | $199.0K | $1.4M | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $30.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $340.0K | $352.0K | $352.0K | $352.0K | $351.0K | $352.0K | $351.0K | $437.0K | |||||||||||||||||||||||||||
| Accrued Liabilities Current | $7.0M | $5.3M | $2.3M | $4.1M | $3.3M | $2.9M | $3.3M | $2.5M | $1.6M | $558.0K | $755.0K | $387.0K | $415.0K | $179.0K | $243.0K | $18.0K | $32.0K | $8.0K | $744.0K | $641.0K | $818.0K | $642.0K | |||||||||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$11.2M | $3.0M | -$13.5M | -$23.7M | $188.7M | $2.5M | -$682.0K | ||||||||||||||||||||||||||||||||||||||||||||
| Accrued Development Expense Current | $1.4M | $3.8M | $4.1M | $2.5M | $1.6M | $1.8M | $7.3M | $448.0K | $207.0K | $25.0K | $337.0K | $332.0K | $301.0K | $742.0K | $572.0K | $382.0K | $793.0K | $605.0K | $419.0K | $754.0K | $576.0K | ||||||||||||||||||||||||||||||
| Other Liabilities Current | $226.0K | $159.0K | $113.0K | $297.0K | $228.0K | $125.0K | $391.0K | $293.0K | $179.0K | $416.0K | $370.0K | $261.0K | $509.0K | $50.0K | $50.0K | $7.0K | $14.0K | $11.0K | $7.0K | $14.0K | |||||||||||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $106.1M | $112.4M | $117.3M | $189.0M | $207.3M | $124.2M | $142.4M | $168.4M | $187.5M | $174.7M | |||||||||||||||||||||||||||||||||||||||||
| Prepaid Expense And Other Assets Current | $2.8M | $2.4M | $2.8M | $13.6M | $14.8M | $9.8M | $7.8M | $8.5M | $7.5M | $8.6M | $7.0M | $12.5M | $10.4M | $1.3M | |||||||||||||||||||||||||||||||||||||
| Marketable Securities Current | $550.0K | $1.5M | $900.0K | $950.0K | $2.0M | $1.1M | $250.0K | $1.3M | $1.3M | $1.3M | $2.8M | $4.3M | $14.9M | $22.1M | $27.7M | $38.2M | |||||||||||||||||||||||||||||||||||
| Operating Lease Right Of Use Asset | $0.00 | $144.0K | $166.0K | $188.0K | $231.0K | $252.0K | $274.0K | $45.0K | $67.0K | $113.0K | $135.0K | $158.0K | |||||||||||||||||||||||||||||||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $2.0K | $43.0K | $96.0K | $121.0K | $394.0K | |||||||||||||||||||||||||||||||||||||
| Operating Lease Liability Current | $0.00 | $102.0K | $100.0K | $99.0K | $95.0K | $93.0K | $84.0K | $58.0K | $45.0K | $67.0K | $90.0K | $90.0K | $90.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | -$239.0K | $124.5M | $2.6M | $47.8M | $192.3M | $75.4M | $5.8M | $14.1M | -$284.0K | -$46.0K | $379.0K | $524.0K | -$34.2M | $8.7M | -$83.3M | $555.0K | |
| Investing Cash Flow * | -$581.0K | -$103.0K | -$414.0K | -$2.7M | -$22.2M | $360.0K | -$18.0K | $2.1M | -$2.2M | -$192.0K | $1.2M | $5.7M | $17.6M | $59.9M | $52.5M | -$103.2M | |
| Operating Cash Flow * | -$32.3M | -$116.9M | -$82.0M | -$77.5M | -$30.2M | -$5.4M | -$2.5M | -$4.8M | -$8.2M | -$12.2M | -$9.1M | -$9.5M | -$6.9M | -$7.2M | -$260.0K | -$143.0K | -$14.7M |
| Share Based Compensation | $19.6M | $16.3M | $4.6M | $2.1M | $1.8M | $988.0K | $1.3M | $2.4M | $3.0M | $4.3M | $3.5M | $3.8M | $3.1M | $6.6M | $5.4M | $20.1M | $6.7M |
| Increase Decrease In Employee Related Liabilities | $268.0K | $1.2M | $30.0K | -$1.7M | $1.8M | $25.0K | -$3.0K | -$248.0K | -$26.0K | -$288.0K | -$29.0K | -$60.0K | -$141.0K | -$62.0K | -$797.0K | $574.0K | -$552.0K |
| Increase Decrease In Accounts Payable | $34.0M | -$2.9M | $6.9M | -$3.4M | $6.2M | $458.0K | $159.0K | -$130.0K | $129.0K | -$711.0K | $841.0K | -$272.0K | $84.0K | -$103.0K | -$643.0K | -$210.0K | -$899.0K |
| Increase Decrease In Accrued Liabilities | -$523.0K | $2.1M | -$58.0K | $621.0K | -$243.0K | $372.0K | -$867.0K | $869.0K | -$616.0K | -$288.0K | $15.0K | $656.0K | -$963.0K | $192.0K | |||
| Increase Decrease In Other Current Assets | $220.0K | $23.0K | $49.0K | -$172.0K | -$86.0K | $87.0K | -$26.0K | $12.0K | -$105.0K | $214.0K | -$266.0K | -$132.0K | |||||
| Payments To Acquire Property Plant And Equipment | $581.0K | $103.0K | $414.0K | $2.7M | $22.2M | $18.0K | $75.0K | $195.0K | $80.0K | ||||||||
| Depreciation Depletion And Amortization | $22.0K | $58.0K | $122.0K | $163.0K | $232.0K | $257.0K | |||||||||||
| Proceeds From Issuance Of Common Stock | $0.00 | $0.00 | $47.3M | $189.8M | $70.3M | $14.1M | $379.0K | $524.0K | -$302.0K | $9.0M | $2.1M | $564.0K | |||||
| Proceeds From Sale And Maturity Of Marketable Securities | $2.1M | $2.1M | $3.9M | $3.9M | $12.3M | $38.4M | $62.4M | $110.8M | $48.4M | ||||||||
| Payments To Acquire Marketable Securities | $399.0K | $4.1M | $3.8M | $2.6M | $6.6M | $20.8M | $2.5M | $65.8M | $154.0M | ||||||||
| Proceeds From Stock Options Exercised | $90.0K | $918.0K | $2.6M | $475.0K | $1.8M | $256.0K | |||||||||||
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | -$94.0K | $53.0K | $27.0K | $9.0K | $36.0K | $19.0K | $25.0K | $4.0K | $142.0K | $95.0K | $75.0K | $60.0K | $35.0K | -$22.0K | |||
| Proceeds From Warrant Exercises | $0.00 | $123.6M | $0.00 | $0.00 | $692.0K | $4.9M | $5.9M | ||||||||||
| Increase Decrease In Other Current Liabilities | -$136.0K | $731.0K | $85.0K | $9.0K | -$3.0K | -$21.0K | |||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$6.1M | -$539.0K | -$1.7M | -$1.2M | $11.0M | $220.0K | |||||||||||
| Increase Decrease In Other Accrued Liabilities | -$3.0K | -$21.0K | -$58.0K | -$15.0K | -$390.0K | -$344.0K | |||||||||||
| Increase Decrease In Operating Lease Right Of Use Assets And Liabilities Net | $0.00 | $0.00 | $17.0K | $9.0K | -$28.0K | $2.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $90.0K | $22.2M | $64.0K | $211.0K | $191.0M | $3.6M | -$60.0K | $1.9M | -$46.0K | $66.0K | $6.0K | $4.4M | ||||||||||||||
| Investing Cash Flow * | $0.00 | $0.00 | -$357.0K | -$425.0K | $100.0K | -$18.0K | $2.1M | -$1.5M | -$2.2M | -$79.0K | $4.1M | $2.7M | $42.4M | |||||||||||||
| Operating Cash Flow * | -$11.3M | -$19.1M | -$13.3M | -$23.5M | -$2.3M | -$1.2M | -$604.0K | -$1.6M | -$1.5M | -$3.1M | -$1.1M | -$2.7M | -$1.9M | -$2.1M | $3.3M | |||||||||||
| Share Based Compensation | $5.2M | $2.3M | $673.0K | $495.0K | $250.0K | $270.0K | $344.0K | $802.0K | $827.0K | $1.7M | $795.0K | $881.0K | $962.0K | $1.1M | $884.0K | $783.0K | $679.0K | $907.0K | $1.3M | |||||||
| Increase Decrease In Employee Related Liabilities | -$502.0K | $28.0K | $42.0K | -$1.7M | $16.0K | $14.0K | $1.0K | -$33.0K | $860.0K | $86.0K | $167.0K | $261.0K | $171.0K | -$212.0K | ||||||||||||
| Increase Decrease In Accounts Payable | -$3.8M | -$47.0K | $155.0K | $201.0K | -$3.0K | $270.0K | $9.0K | $82.0K | -$17.0K | $5.0K | $38.0K | -$671.0K | ||||||||||||||
| Increase Decrease In Accrued Liabilities | $122.0K | $834.0K | -$390.0K | $87.0K | -$381.0K | -$19.0K | -$76.0K | $182.0K | -$340.0K | -$547.0K | -$495.0K | $177.0K | ||||||||||||||
| Increase Decrease In Other Current Assets | -$185.0K | $9.0K | -$93.0K | -$72.0K | -$230.0K | -$139.0K | -$120.0K | -$124.0K | -$126.0K | $117.0K | -$5.2M | |||||||||||||||
| Payments To Acquire Property Plant And Equipment | $0.00 | $0.00 | $357.0K | $425.0K | $18.0K | $195.0K | $79.0K | |||||||||||||||||||
| Depreciation Depletion And Amortization | $1.0K | $14.0K | $17.0K | $17.0K | $18.0K | $14.0K | $4.0K | $3.0K | $35.0K | $53.0K | ||||||||||||||||
| Proceeds From Issuance Of Common Stock | $189.8M | $1.9M | $66.0K | $6.0K | $4.4M | |||||||||||||||||||||
| Proceeds From Sale And Maturity Of Marketable Securities | $2.1M | $1.3M | $6.9M | $7.5M | $42.4M | |||||||||||||||||||||
| Payments To Acquire Marketable Securities | $399.0K | $1.5M | $2.0M | $1.3M | $2.8M | $4.8M | ||||||||||||||||||||
| Proceeds From Stock Options Exercised | $90.0K | $0.00 | $464.0K | $889.0K | $64.0K | $211.0K | $475.0K | $256.0K | ||||||||||||||||||
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $23.0K | $23.0K | $23.0K | $23.0K | $24.0K | $24.0K | $5.0K | $1.0K | ||||||||||||||||||
| Proceeds From Warrant Exercises | $0.00 | $22.2M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $692.0K | $3.6M | ||||||||||||||||
| Increase Decrease In Other Current Liabilities | -$313.0K | -$370.0K | -$44.0K | $2.0K | $12.0K | $10.0K | ||||||||||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$5.1M | $1.3M | -$2.7M | $1.1M | -$185.0K | |||||||||||||||||||||
| Increase Decrease In Other Accrued Liabilities | $7.0K | -$24.0K | -$48.0K | -$3.0K | ||||||||||||||||||||||
| Increase Decrease In Operating Lease Right Of Use Assets And Liabilities Net | $0.00 | $17.0K | $1.0K | -$25.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.88 | -$1.46 | -$2.32 | -$1.90 | -$0.82 | -$0.24 | -$0.27 | -$0.61 | -$1.82 | -$2.28 | -$0.31 | -$0.27 | $0.70 | -$0.08 | -$0.06 | -$0.28 | -$0.08 |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 39.4M | 26.1M | 17.4M | 10.7M | 6.5M | 6.5M | 45.4M | 45.3M | 44.8K | 44.2K | 42.6K | 42.2M | |||||
| Common Stock Shares Outstanding | 48.3M | 48.2M | 42.2M | 41.7M | 40.0M | 35.2M | 46.1M | 6.6M | 45.8M | 45.8M | 45.5M | 45.3M | 44.7M | 42.9M | |||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Issued | 48.3M | 48.2M | 42.2M | 41.7M | 40.0M | 35.2M | 21.8M | 17.2M | 6.6M | 6.6M | 45.8M | 45.8M | 45.5M | 45.3M | 45.3M | 42.9M | |
| Common Stock Shares Authorized | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Per Share Basic | $-1.88 | $-0.53 | $-2.32 | $-1.90 | $-0.82 | $-0.31 | $-0.27 | $0.70 | $-0.08 | $-0.06 | |||||||
| Weighted Average Number Of Shares Outstanding Basic | 48.3M | 46.3M | 41.9M | 40.2M | 39.4M | 45.8M | 45.3M | 45.0M | 44.8M | 44.2M | |||||||
| Weighted Average Number Of Diluted Shares Outstanding | 48.3M | 46.6M | 41.9M | 40.2M | 45.8M | 45.3M | 45.2M | 44.8M | 44.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q1 2012 | Q4 2011 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.22 | -$0.92 | -$0.48 | -$0.58 | $0.13 | -$0.43 | -$0.61 | -$0.63 | -$0.58 | -$0.48 | -$0.44 | -$0.24 | -$0.13 | -$0.09 | -$0.06 | -$0.05 | -$0.05 | -$0.04 | -$0.06 | -$0.08 | -$0.11 | -$0.36 | -$0.33 | -$0.40 | -$0.64 | -$0.42 | -$0.06 | -$0.54 | -$0.46 | -$0.13 | -$0.10 | -$0.08 | -$0.07 | -$0.06 | -$0.05 | -$0.08 | -$0.07 | -$0.08 | $0.72 | -$0.02 | -$0.01 | -$0.01 | -$0.04 | -$0.03 | $0.00 | $0.00 | -$0.01 | -$0.02 | -$0.03 | $0.00 | -$0.02 | -$0.02 | ||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 40.0M | 40.0M | 37.7M | 25.0M | 24.8M | 24.5M | 17.2M | 17.2M | 17.2M | 12.0M | 6.8M | 6.6M | 6.5M | 6.5M | 6.5M | 6.5M | 6.5M | 45.4M | 45.4M | 45.4M | 45.4M | 45.3M | 45.2M | 45.1M | 45.0M | 45.0M | 44.9M | 44.6M | 44.8M | 44.6K | 44.2K | 42.7M | 42.7M | |||||||||||||||||||||||
| Common Stock Shares Outstanding | 48.3M | 48.3M | 48.3M | 48.0M | 48.0M | 43.2M | 42.1M | 41.9M | 41.7M | 40.1M | 40.1M | 40.0M | 40.0M | 40.0M | 40.0M | 25.6M | 24.9M | 24.7M | 21.8M | 17.2M | 17.2M | 17.2M | 17.2M | 17.2M | 6.9M | 6.9M | 6.6M | |||||||||||||||||||||||||||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | ||||||||||||||||||||||||||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||||||||||||
| Common Stock Shares Issued | 48.3M | 48.3M | 48.3M | 48.0M | 48.0M | 43.2M | 42.1M | 41.9M | 41.7M | 40.1M | 40.1M | 40.0M | 40.0M | 40.0M | 40.0M | 25.6M | 24.9M | 24.7M | 17.2M | 17.2M | 17.2M | 17.2M | 6.9M | 6.9M | ||||||||||||||||||||||||||||||||
| Common Stock Shares Authorized | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | ||||||||||||||||||||||||||||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||||||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||||||||||||||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||||||||||||||||||||||
| Earnings Per Share Basic | $-0.22 | $-0.92 | $-0.48 | $-0.58 | $0.13 | $0.58 | $-0.61 | $-0.63 | $-0.58 | $-0.51 | $-0.48 | $0.73 | $-0.02 | $-0.01 | $-0.01 | |||||||||||||||||||||||||||||||||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 48.3M | 48.3M | 48.3M | 48.0M | 46.2M | 43.0M | 42.0M | 41.8M | 41.7M | 40.1M | 40.0M | 44.9M | 44.7M | 43.1M | ||||||||||||||||||||||||||||||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 48.3M | 48.3M | 48.3M | 48.0M | 46.2M | 44.1M | 42.0M | 41.8M | 41.7M | 40.0M | 40.0M | 44.9M | 44.8M | 43.1M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest And Other Income | $2.8M | $49.0K | $112.0K | $328.0K | $105.0K | $38.0K | $107.0K | $57.0K | $47.0K | $106.0K | $451.0K | $901.0K | $1.7M | $1.8M | |||
| Additional Paid In Capital | $570.4M | $550.8M | $518.2M | $511.0M | $461.2M | $267.1M | $190.7M | $183.6M | $167.1M | $164.1M | $160.0M | $156.5M | $152.4M | $148.7M | $176.4M | $162.0M | |
| Stock Issued During Period Value Stock Options Exercised | $90.0K | $918.0K | $2.6M | $475.0K | $1.8M | $256.0K | $379.0K | $492.0K | -$366.0K | $8.9M | $1.9M | $436.0K | |||||
| Other Noncash Income | $2.0K | $8.0K | $4.0K | $2.0K | $10.0K | -$342.0K | -$1.1M | -$1.3M | -$22.0K | ||||||||
| Depreciation | $903.0K | $952.0K | $1.1M | $804.0K | $310.0K | $22.0K | |||||||||||
| Stock Issued During Period Value Employee Stock Ownership Plan | $2.0M | $1.7M | $961.0K | $1.3M | $2.4M | $3.0M | $3.5M | $3.5M | $3.6M | $32.0K | $64.0K | $122.0K | $144.0K | $128.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest And Other Income | $2.2M | $2.1M | $878.0K | $314.0K | $31.0K | $15.0K | $13.0K | $7.0K | $7.0K | $27.0K | $72.0K | $82.0K | $94.0K | $92.0K | $17.0K | $9.0K | $7.0K | $6.0K | $6.0K | $21.0K | $23.0K | $29.0K | $34.0K | $15.0K | $13.0K | $12.0K | $11.0K | $11.0K | $14.0K | $14.0K | $18.0K | $35.0K | $105.0K | $123.0K | $178.0K | $208.0K | $228.0K | ||||||||
| Additional Paid In Capital | $565.1M | $560.7M | $556.1M | $544.1M | $538.5M | $434.3M | $514.9M | $513.5M | $511.8M | $463.1M | $462.5M | $461.9M | $460.7M | $460.0M | $459.6M | $196.3M | $195.0M | $194.5M | $184.5M | $184.2M | $183.9M | $183.2M | $170.6M | $169.9M | $166.3M | $165.7M | $164.9M | $163.2M | $162.4M | $161.7M | $159.1M | $158.3M | $157.5M | $155.5M | $154.4M | $153.2M | $151.3M | $150.5M | $149.4M | $180.1M | $178.4M | $177.3M | $175.1M | $173.6M | |
| Stock Issued During Period Value Stock Options Exercised | $0.00 | $90.0K | $101.4M | $464.0K | $889.0K | $64.0K | $136.0K | $119.0K | $211.0K | $75.0K | $3.0K | $692.0K | |||||||||||||||||||||||||||||||||
| Other Noncash Income | $2.0K | $3.0K | $7.0K | -$133.0K | -$386.0K | ||||||||||||||||||||||||||||||||||||||||
| Depreciation | $200.0K | $200.0K | $220.0K | $200.0K | $300.0K | $311.0K | $273.0K | $272.0K | $272.0K | $181.0K | $174.0K | $178.0K | $121.0K | $8.0K | $1.0K | ||||||||||||||||||||||||||||||
| Stock Issued During Period Value Employee Stock Ownership Plan | $812.0K | $650.0K | $447.0K | $462.0K | $471.0K | $548.0K | $410.0K | $249.0K |
Most recent annual filing with the SEC: March 12, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.